BofA analyst Michael Ryskin lowered the firm’s price target on Avantor to $24 from $27 and keeps a Buy rating on the shares following quarterly results. The firm pointed out in a research on Friday that Q2 sales fell 4% short of BofA/Street estimates, with “core organic” ex-COVID decline of -6.5% and adjusted EPS of 28c. FY23 guide was cut to overall organic decline of -9% to -7% with ex-COVID growth of -6.5% to -4.5%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AVTR: